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Non-technical summary Mucin secretion in the lung is regulated by the soluble
N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) exocytotic core, which
has not been defined in airway goblet cells. In this study, the SNARE vesicle-associated membrane
protein 8 (VAMP8) was found to be expressed in human airway epithelial goblet cells. VAMP8
knockdown by RNA interference techniques reduced airway epithelial mucin secretion induced by
PAR agonists, neutrophil elastase and ATP. Basal (non-agonist elicited) mucin secretion was also
reduced as a result of VAMP8 knockdown. Importantly, mucin secretion was reduced in the lungs
of VAMP8 knockout mice compared to wild-type littermates. Our data suggest that VAMP8 is an
essential SNARE in airway mucin granule exocytosis. Reduction of VAMP8 activity/expression
may provide a novel therapeutic target to ameliorate airway mucus obstruction in lung diseases.
Abstract Mucin secretion is an innate defence mechanism, which is noxiously upregulated in
obstructive lung diseases (e.g. chronic obstructive pulmonary disease (COPD), cystic fibrosis and
asthma). Mucin granule exocytosis is regulated by specific protein complexes, but the SNARE
exocytotic core has not been defined in airway goblet cells. In this study, we identify VAMP8 as
one of the SNAREs regulating mucin granule exocytosis. VAMP8 mRNA was present in human
airway and lung epithelial cells, and deep-sequencing and expression analyses of airway epithelial
cells revealed that VAMP8 transcripts were expressed at 10 times higher levels than other VAMP
mRNAs. In human airway epithelial cell cultures and freshly excised tissues, VAMP8 immuno-
localised mainly to goblet cell mucin granules. The function of VAMP8 in airway mucin secretion
was tested by RNA interference techniques. Both VAMP8 short interfering RNAs (siRNAs) and
short hairpin RNAs (shRNAs) reduced mucin secretion induced by PAR agonists, neutrophil
elastase and ATP in two airway epithelial cell culture models. Notably, basal (non-agonist
elicited) mucin secretion was also reduced in these experiments. VAMP8 knockdown was also
effective in decreasing mucin secretion in airway epithelial cell cultures with induced mucous
metaplasia/mucin hypersecretion. Unlike VAMP8 silencing, knockdown of VAMP2 or VAMP3
did not affect mucin secretion. Importantly, in VAMP8 knock-out (KO) mice with IL-13-induced
mucous metaplasia, mucin content in the bronchoalveolar lavage (BAL) and ATP-stimulated
mucin secretion in the trachea were reduced compared to WT-matched littermates. Our data
indicate that VAMP8 is an essential SNARE in airway mucin granule exocytosis. Reduction of
VAMP8 activity/expression may provide a novel therapeutic target to ameliorate airway mucus
obstruction in lung diseases.
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Abbreviations AB-PAS, Alcian blue periodic acid Schiff; ATPγS, adenosine triphosphate-γ-sulfate; BAL, broncho-
alveolar lavage; CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane conductance regulator; COPD, chronic
obstructive pulmonary disease; KO, knockout; MARCKS, myristoylated, alanine-rich C-kinase substrate; MCC,
mucociliary clearance; PABH, periodic acid biotin hydrazide; PAR, protease activated receptor; qRT-PCR, quantitative
RT-PCR; RPKM, read per kilobase of exon model; shRNA, short hairpin RNA; siRNA, short interfering RNA; SMM,
supernatant of mucopurulent material from CF lungs; SNARE, soluble N-ethylmaleimide-sensitive factor attachment
protein receptor; t-SNARE, target membrane SNARE;VAMP8, vesicle-associated membrane protein 8; v-SNARE, vesicle
membrane SNARE; WD-HBE cells, well-differentiated primary human bronchial epithelial cells.
Introduction
Mucociliary clearance (MCC) is a key innate defence
mechanism of human airways (Boucher, 2007). A
major element of the MCC mechanism is the thin
mucus layer covering the airway surface, which provides
hydration, lubrication and clearance of particles and
pathogens from the airways. The surface mucus layer
is composed of water, electrolytes and macromolecules,
but gel-forming mucins (i.e. MUC5AC and MUC5B),
which are complex glycosylated macromolecules, are
responsible for the biophysical characteristics of the mucus
film. Not surprisingly, the secretion of mucins into the
airway lumen is a tightly regulated process, occurring
via calcium-dependent exocytosis of specialised granules
from epithelial goblet (mucous) cells, and dysregulated
mucin secretion adversely perturbs MCC activities leading
to the development of obstructive lung disease (Kreda et al.
2007, 2010b; Davis & Dickey, 2008; Evans & Koo, 2009).
Mucin secretion is a multi-step process and requires
the recruitment of specific proteins that facilitate the
exocytosis of the mucin granule, but only a few of
these proteins have been identified in airway goblet cells.
Munc 13-2, which is activated by diacylglycerol mobilised
during agonist stimulation, is a priming protein for
mucin granule exocytosis, and deletion of Munc 13-2
affects tonic mucin secretion in the mouse airways (Zhu
et al. 2008). Synaptotagmin 2, one of three low-affinity
Ca2+ sensors that trigger fast synaptic vesicle release
in neurons, mediates acute agonist-stimulated mucin
secretion in mouse airway goblet cells (Tuvim et al.
2009). The myristoylated, alanine-rich C-kinase sub-
strate (MARCKS) protein has also been implicated in the
priming of the mucin granule (Li et al. 2001), and an
inhibitory MARCKS peptide has been shown to decrease
airway mucin secretion in an asthma mouse model
(Singer et al. 2004). However, the SNARE proteins, which
associate to form the minimal exocytotic machinery – the
‘exocytotic or SNARE core’, have not been identified in air-
way goblet cells. In neuronal and exocrine secretory cells,
the exocytotic core is formed by the specific interaction
of two or three different t-SNAREs (target membrane
SNAREs) or Q-SNAREs with one v-SNARE (vesicle
membrane SNARE) or R–SNARE (Burgoyne & Morgan,
2003; Davis & Dickey, 2008).
Endobrevin, or VAMP8 (vesicular associated
membrane protein 8), is a v-SNARE. Initially, VAMP8
was identified as an endosomal v-SNARE, but more
recent data demonstrated that it might not be essential for
endocytosis (Wang et al. 2004). Immunohistochemical
studies show that VAMP8 is expressed in exocrine tissues
such as pancreatic, salivary, lachrymal, sweat, sebaceous,
mammary and prostate glands (Wang et al. 2007). A
major physiological role of VAMP8 has been recently
revealed by studies in the VAMP8 knockout (KO) mouse,
which indicated that VAMP8 is a crucial vesicular SNARE
in regulated exocytosis from exocrine cells (Wang et al.
2004). For example, the VAMP8 KO mouse exhibited
reduced agonist-elicited secretion of zymogen granules
from pancreatic acinar cells and dense granules from
salivary and lachrymal acinar cells (Wang et al. 2004,
2007). VAMP8 deficiency also affects agonist-stimulated
secretion of histamine granules from mast cells ex vivo and
in vivo, and regulated secretion of dense and α-granules
from platelets and thrombus formation after injury in
vivo (Ren et al. 2007; Tiwari et al. 2008; Graham et al.
2009). Regulated secretion from endocrine pancreatic
cells or of cytokines/chemokines from mast cells was not
affected in the VAMP8 KO mouse (Wang et al. 2004;
Tiwari et al. 2008). Thus, VAMP8 appears to display tissue
specificity for regulated exocytotic pathways (Tiwari et al.
2008).
We recently discovered that VAMP8 is associated with
mucin granules purified from airway goblet cell-like
Calu-3 cells (Kreda et al. 2010b). Moreover, VAMP8
was associated with mucin granules in resting goblet
cells, but was diffusely distributed within the cells after
agonist-stimulated exocytosis of mucin granules (Kreda
et al. 2010b). Thus, it is plausible that VAMP8 is involved
in the regulation of mucin granule exocytosis in the air-
way goblet cell. In this study, we tested the hypothesis
that VAMP8 is a critical element for mucin exocytosis
in airway goblet cells using RNA interference techniques.
We then explored the role of VAMP8 mediating mucin
secretion in the VAMP8 KO mouse. Identification of
essential regulators/mediators of mucin granule exocytosis
is important for designing effective therapies to ameliorate
mucin secretion in mucus hypersecretory and obstructive
lung diseases.
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Methods
Human cell culture and tissues
Calu-3 cells were cultivated as described in Kreda
et al. (2007 and 2010b). Well-differentiated human
bronchial epithelial (WD-HBE) cell cultures were grown
on collagen-coated permeable supports (Corning Inc.;
Corning, NY, USA) under air–liquid interface conditions,
as previously described in Kreda et al. (2005 and 2010b).
For IL-13 studies, WD-HBE cells were incubated with
IL–13 (basolateral, 10 ng ml−1) in growth media for
3–5 days after differentiation as in Okada et al. (2011). For
supernatant of mucopurulent material (SMM) treatment,
WD-HBE cells were treated apically with SMM for 5 days
as described previously (Ribeiro et al. 2005). Human
airway epithelial tissues for immunocytochemistry and
cell culture were obtained from excess tissue from cystic
fibrosis patients undergoing lung transplant and tissues
from normal donors, according to the guidelines of the
Institutional Review Board for Protection of Human
Rights at the University of North Carolina at Chapel Hill.
VAMP8 knockout animals
The VAMP8 knockout (KO) mouse was obtained from
Dr Sidney Whiteheart (University of Kentucky) and has
been previously described (Wang et al. 2004). Mice
were housed at the UNC Chapel Hill animal facility
on a 12 h day–night cycle, and they had access to
a regular chow diet and water ad libitum. Animals
heterozygous for the VAMP8 deletion were bred to
generate wild-type (WT), heterozygous (HET) and homo-
zygous (KO) littermates. VAMP8 KO were born at
Mendelian rates, but exhibited ≤30% mortality within
the first 2 weeks of life as previously reported (Wang
et al. 2004). To induce airway mucous metaplasia, IL-13
treatment was performed on 8–week-old mice by intra-
tracheal instillation of 50 μl of PBS containing 1 μg
murine recombinant IL-13 or PBS alone as described in
Zhu et al. (2008). Three days after IL-13 administration,
mice were killed by exsanguination under deep avertin
(2,2,2-tribromoethanol) anaesthesia administered I.P.
(500 mg (kg body weight)−1) in accordance with UNC-CH
(USA) and UK regulations on animal experimentation;
the authors have read, and the experiments comply with
the policies and regulations of The Journal of Physiology
given by Drummond (2009). The chest cavity was opened
and tracheas were quickly dissected from the larynx to the
point just before the tracheal carina, and kept in ice-cold
Hank’s buffered saline solution with 1.6 mM calcium,
1.8 mM magnesium and 25 mM Hepes (pH 7.4) (HBSS)
until the experiments (see below). After dissecting the
trachea, broncho-alveolar lavage (BAL) was performed
as described in Mall et al. (2008) and Zhu et al. (2008).
All animal studies were approved by the Institutional
Animal Care and Use Committee of the University of
North Carolina at Chapel Hill and performed according
to the principles outlined by the Animal Welfare and the
National Institutes of Health guidelines for the care and
use of animals in biomedical research.
Short interfering RNA (siRNA) transfection of airway
epithelial cells
For transient siRNA transfections, Calu-3 cells were
dissociated by trypsinization and transfected with four
ON-TARGET plus siRNAs for VAMP8, VAMP2 or VAMP3
(Dharmacon; Lafayette CO, USA) using the AMAXA
System (1 μg RNA per 106 cells; Lonza, Walkersville,
MD, USA; per manufacturer instructions) as described
in Seminario-Vidal et al. (2009). GAPDH siRNA or
siGlo Green (1 μg RNA per 106 cells) were used as
controls. Cells were cultured for at least 96 h before they
were assayed for mRNA and protein expression, and
mucin secretion. Effective siRNA sequences for VAMP8
knockdown (‘A’: GGGAAAACUUGGAACAUCU; ‘B’:
CCACUGGUGCCUUCUCUUA; ‘C’: GUCCUUAUC
UGCGUGAUUG) were cloned as shRNAs (see below).
Short hairpin RNA (shRNA) vector expression
in airway epithelial cells
VAMP8 shRNA expression was achieved in Calu-3
cells by infecting partially confluent Calu-3 cells with
retroviral pSIREN vectors (Clontech, Mountain View,
CA, USA). Cells infected with empty vector or a
vector encoding an effective VAMP8 siRNA sequence
were selected with puromycin, and used within the
first 10 passages. For VAMP8 shRNA expression in
WD-HBE cell cultures, passage 1 undifferentiated HBE
cells grown on plastic dishes were infected with mock
or VAMP8 shRNA-encoding pSIREN vectors. Cells were
selected with puromycin, passaged onto collagen-coated
permeable supports, and grown under air–liquid inter-
face for 4–6 weeks for epithelial differentiation prior to
the experiments.
Quantitative (q)RT-PCR
Quantitative RT-PCR was performed to evaluate mRNA
levels, as described previously (Seminario-Vidal
et al. 2009; Kreda et al. 2010b). The primers






-gaccctcctggcacacattt.; human VAMP-2 forward:
5
′
-ctttccgtcccgggcagcc and reverse: 5
′
-gcggt
agcagacatggcggg; human VAMP-3 forward: 5
′
-gccgtc
ccacccatctccct and reverse: 5
′
-tcccgattgcccacatcttgc;
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primers for human VAMP-7, MUC5AC and MUC5B
were purchased from Applied Biosystems (Carlsbad, CA,
USA).
mRNA deep sequencing of airway epithelial cells
Total RNA was isolated from Calu–3 cells, as described
in Seminario-Vidal et al. (2009) and Kreda et al.
(2010b). RNA integrity was evaluated by running 100 ng
of RNA on an Agilent Technologies 2100 Bioanalyzer
(Agilent Technologies; Santa Clara, CA, USA); the RNA
integrity number was 10, the highest quality number.
The RNA library was prepared using 2 μg of total
RNA and Illumina’s mRNA Sequencing Sample Pre-
paration kit (Illumina; San Diego, CA, USA). The resulting
library quality was validated on an Agilent Bioanalyzer
using an Agilent DNA-1000 chip. The size, purity and
concentration of the library met all criteria for mRNA
sequencing. The library was sequenced in the UNC High
Throughput Sequencing Facility (UNC Chapel Hill), using
Illumina 2X36 sequencing. Data were compiled using the
updated human genomic database.
Immunofluorescence analyses
Human tissues and WD-HBE cells were fixed in buffered
formalin and embedded in paraffin. Tissue and cell
culture sections were deparaffinised, subjected to epitope
retrieval (Dako, Carpinteria, CA, USA; per manufacturer’s
instructions) (Kreda & Gentzsch, 2011), and immuno-
stained with antibodies against VAMP8 and human
MUC5AC, as described previously (Kreda et al. 2005,
2010b). Immunofluorescence analyses were conducted
in a Leica SP5 confocal microscope system with three
independent laser sources (Leica; Heidelberg, Germany).
Mucin secretion experiments in airway epithelial cells
Mucin secretion was measured in Calu-3 and WD-HBE
cells, as we previously described in Kreda et al. (2007
and 2010b). Briefly, basal secretion was estimated by
incubating cultures in HBSS for at least 2 h at 37◦C in
the absence of agonist stimulation. Agonist-stimulated
mucin secretion was assessed by incubating the cell
cultures for an additional 10–20 min with agonists (or
vehicle, as a control), as indicated in the figure legends.
Cell culture supernatants were collected in basal and
agonist-stimulated conditions, and mucin secretion was
assessed by slot blot using an antibody against human
MUC5AC, as we previously described in Kreda et al.
(2007 and 2010b). In some experiments, slot blots were
developed by the periodic acid biotin hydrazide (PABH)
method to assess total secreted mucins (Conway et al.
2003).
At the end of each experiment, WD-HBE cell cultures
were incubated undisturbed for at least 24 h before
they were fixed, paraffin-embedded and stained using
the Alcian blue periodic acid Schiff (AB-PAS) method
(Zhu et al. 2008); staining quantification was performed
in three to five fields per culture, three cultures per
condition, using Adobe Photoshop software. Calu-3 cells,
undisturbed for at least 24 h, were fixed and stained with
a (human) MUC5AC antibody; staining quantification
was performed as described in Kreda et al. (2010b).
Undisturbed cultures (>24 h) were lysed (Kreda et al.
2005) and assayed for VAMP and MUC5AC protein levels
(Kreda et al. 2007, 2010b).
Mucin exocytosis in ex vivo mouse tracheas
Tracheas quickly removed from WT and VAMP8 HET
and VAMP8 KO mice were incubated in HBSS with or
without 1 mM ATP for 20 min at 37◦C. Tracheas were
fixed in buffered formalin, paraffin-embedded, sectioned
along the longitudinal axis (5–μm-thick sections), and
stained with AB-PAS to label mucous cells using standard
histological protocols. Three images per trachea were
obtained in a Nikon Microphot SA with a DXM 1200
camera (Melville, NY, USA) using identical conditions
throughout the study. AB-PAS staining was quantified
using Adobe Photoshop software by thresholding the
AB-PAS staining and quantifying the number of pixels
per length unit of trachea.
Mucin content in mouse BALs
BAL samples were processed to solubilize mucins and
separated in a 1% agarose gel (1 g (100 ml)−1) and
transferred onto a blotting membrane as described in
Livraghi et al. (2009). To assess MUC5B, membranes
were blotted with polyclonal antibodies that specifically
recognize mouse MUC5B (Zhu et al. 2008) followed
by a fluorescently labelled secondary antibody, and
membranes were visualized using a LI-COR infrared
scanner system (LI-COR Biosciences) and quantified as
previously described (Kreda et al. 2010b).
Reagents
ATPγS was obtained from Sigma (St Louis, MO, USA);
human neutrophil elastase was from Elastin Products
(Owensville, MI, USA); human α-thrombin was from
Enzyme Research Laboratories (South Bend, IN, USA);
IL-13 was from PeproTech (Rocky Hill, NJ, USA); MUC5B
antibodies were a kind gift from Dr C. Ehre (Zhu
et al. 2008), MUC5AC antibodies (Kreda et al. 2007)
were purchased from LabVision (Fremont, CA, USA).
VAMP-8 antibodies (Kreda et al. 2010b), VAMP2 and
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VAMP3 antibodies were from Abcam (USA) and Synaptic
Systems (Germany). Secondary antibodies were from
Jackson ImmunoResearch Labs (West Grove, PA, USA)
and LI-COR (Lincoln, NE, USA). PAR1 and PAR2 peptides
were prepared as in Kreda et al. (2010b). VAMP8, VAMP2
and VAMP3 siRNAs, and siGlo Green were purchased from
Dharmacon (Lafayette, CO, USA). Other chemicals were
of the highest purity available and from sources previously
reported.
Statistics
Student’s paired t test was performed using Excel 2010;
P < 0.01 was accepted to indicate statistical significance.
Results
VAMP8 is expressed in airway goblet cells
We have recently reported that VAMP8 was present in
mucin granules purified from Calu-3 cells, a cell culture
model of airway goblet cells (Kreda et al. 2010b). Immuno-
staining studies in well-differentiated primary human
bronchial epithelial (WD-HBE) cell cultures indicated that
VAMP8 was localised almost exclusively to mucin granules
in goblet cells (identified with a MUC5AC antibody; Kreda
et al. 2005, 2007) (Fig. 1A). RT-PCR analysis confirmed
that VAMP8 was expressed in native airway epithelium
(bronchus and trachea), lung, WD-HBE cells and goblet
cell-like Calu-3 cells (Fig. 1B).
VAMP8 was the predominant v-SNARE in human
airway epithelial cells, as indicated by deep sequencing
analysis of Calu-3 cells (Table 1). The analysis of the
data expressed as RPKM (read per kilobase of exon
model; Mortazavi et al. 2008) showed that VAMP8 was
expressed ∼5 times higher than VAMP3, 10–14 times
higher than VAMP5 and VAMP7, ∼30 times higher
than VAMP2, and >100 times higher than VAMP1 and
VAMP4 (Table 1). Similar results were observed by deep
sequencing of WD-HBE cells (S. Randell, unpublished
results). VAMP2 and VAMP3 have been implicated
in exocytosis of neuronal, gland acinar and mast cell
granules (Deak et al. 2004; Wang et al. 2004; Pocard
et al. 2007; Weng et al. 2007; Tiwari et al. 2009; Hasan
et al. 2010), while VAMP7 but not VAMP5 has been
described to participate in vesicle exocytosis (Hasan et al.
2010). Quantitative RT-PCR analysis of WD-HBE and
Calu-3 cells confirmed that VAMP8 was more abundantly
expressed (10–25 times) that VAMP2, VAMP3 and VAMP7
Figure 1. VAMP8 is expressed in lung tissues and
airway epithelial cells
A, immunostaining of VAMP8 and MUC5AC in WD-HBE
cells. Confocal microscopy images of MUC5AC mucin
granule immunostaining (green) overlaid with the
DIC/Nomarski channel (grey), VAMP8 immunostaining (red),
and overlay of MUC5AC and VAMP8 immunostaining
channels (yellow). Both proteins localize in ∼1 μm diameter
mucin granules in the goblet cells of WD-HBE cells; scale bar,
10 μm. B, RT-PCR analysis. A single PCR product (268 bp),
encoding VAMP8 sequence, is present in human airway
epithelial cells and native tissues. C, relative expression of
VAMP2, VAMP3 and VAMP7 to VAMP8 transcripts in Calu-3
and WD-HBE cells. mRNA expression levels of VAMP2,
VAMP3, VAMP7 and VAMP8 were measured by qRT-PCR in
Calu-3 and WD-HBE cells. The data were normalised to 18S
transcript levels and are expressed in relationship to VAMP8
transcript levels (VAMP8 = 1); n = 4.
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The Calu-3 cell transcriptome was subjected to
deep sequencing as described in Methods. Trans-
cripts were identified using the updated version
of the human genomic annotation database,
and the data were expressed as RPKM (read per
kilobase of exon model) as an estimation of the
expression levels of each transcript. The relative
RPKM values for all VAMPs compared to VAMP8
(VAMP8 = 1) shown in the last column indicate
that VAMP8 is the most abundantly expressed
VAMP in Calu-3 cells.
(Fig. 1C). These data suggest that VAMP8 may have a
dominant role in airway goblet cells.
Immunolocalisation studies, using antibodies against
human MUC5AC to identify mucous cells in the
surface epithelium, demonstrated that VAMP8 was
associated with goblet cell mucin granules in human
normal bronchial superficial epithelial tissues, while
MUC5AC-negative cells (non-goblet cells) displayed low
or negligible levels of VAMP8 immunostaining (Fig. 2Aa).
In cystic fibrosis (CF) airway epithelium, chronic infection
and inflammation induces mucous cell metaplasia, and
thus, a higher number of goblet cells and MUC5AC mucin
granules were observed compared to non-CF airway
epithelium (Fig. 2Ab), as previously reported (Kreda et al.
2005; Evans & Koo, 2009). In CF bronchial epithelium,
VAMP8 was also associated with MUC5AC goblet cell
granules, but the immunostaining signal was greater than
in normal airways (Fig. 2A). This increase in VAMP8
immunostaining was consistent with the metaplastic
increase of goblet cell numbers present in these tissues.
Evidence for this assertion was generated from studies
of WD-HBE cells cultured from non-CF and CF
Figure 2. VAMP8 and MUC5AC immunostaining in
non-CF and CF human airway epithelia
A, freshly excised human bronchial tissues. Confocal
microscopy images of MUC5AC
(green) + DIC/Nomarski (grey) overlay, VAMP8 (red),
and VAMP8 + MUC5AC overlay. MUC5AC and VAMP8
antibodies labelled the mucin granules of goblet cells
within the surface epithelium of bronchial tissues,
non-CF (a) and CF (b) displaying mucous metaplasia
(bottom panels); scale bar, 20 μm. B, WD-HBE cell
cultures. Confocal microscopy images of MUC5AC
(green) + DIC/Nomarski (grey) overlay, VAMP8 (red),
and VAMP8 + MUC5AC overlay in WD-HBE cell
cultures, non-CF (a), CF (b), and non-CF with
IL-13-induced mucous metaplasia (c); scale bar, 20 μm.
Note, VAMP8 localised with MUC5AC mucin granules,
but it was also associated with apical granules within
MUC5AC-negative cells of IL-13-induced WD-HBE cells;
these cells probably expressed MUC5B granules, which
are not recognised by the MUC5AC antibody.
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individuals, indicating that similar VAMP8 immuno-
staining was observed in both genotypes (Fig. 2Ba and
b, non-CF and CF, respectively). These results reflect the
fact that CF airway epithelial cells, in the absence of
the native chronic infection/inflammation, differentiate
into epithelial cultures with a relative low number
of goblet cells, similar to non-CF cultures (Kreda
et al. 2005). In contrast, non-CF cultures with mucous
metaplasia induced by IL-13 treatment (Okada et al. 2011)
displayed increased VAMP8 immunostaining associated
with augmented mucous cell numbers (Fig. 2Bc).
Knockdown of VAMP8 expression reduces mucin
secretion in Calu-3 cells
To test the function of VAMP8 in mucin secretion,
VAMP8 expression was knocked-down using RNA inter-
ference techniques. Calu-3 cells were transfected with a
mix of four different short interfering RNAs (siRNAs).
After 96 h, the mRNA levels of VAMP8 were profoundly
reduced (Fig. 3A), but the mRNA levels of MUC5AC or
other VAMPs expressed in airway epithelium were not
affected (mRNA levels in VAMP8 compared to GAPDH
siRNA-transfected Calu-3 cells for MUC5AC: 100 ± 7%,
VAMP2: 98 ± 8% and VAMP3: 103 ± 4%). The protein
levels of VAMP8 (Fig. 3B) were significantly reduced, while
the levels of MUC5AC protein (Fig. 3C) were unaffected.
Next, mucin secretion was evaluated in VAMP8 silenced
Calu-3 cells. Airway goblet cells release mucin at a constant
rate in the absence of external stimuli; this type of secretion
is defined as ‘tonic’ or ‘basal’ secretion. Mucin (human
MUC5AC) secretion under basal conditions was estimated
by incubating cell cultures with vehicle for 2 h in the
absence of external agonist or stimulus (note: mucin
secreted levels are higher after 2 h incubation (basal) than
after 10 min incubation with vehicle (vehicle), Fig 3D). In
these conditions, basal mucin secretion was significantly
reduced by VAMP8 knockdown. Mucin secretion was
significantly increased in cells stimulated with protease
activated receptor (PAR) agonists compared to cells
incubated in vehicle, as previously reported (Kreda et al.
2010b). Importantly, agonist-stimulated mucin secretion
was profoundly decreased in cells transfected with VAMP8
siRNAs (Fig. 3D).
To control for the specificity of the effect of VAMP8
silencing in reducing mucin secretion, similar experiments
were conducted to knockdown VAMP2 or VAMP3
expression. VAMP2 and VAMP3 have been implicated in
the regulation of exocytosis of mast cell and gland acinar
granules (Wang et al. 2004; Pocard et al. 2007; Weng et al.
2007; Tiwari et al. 2009; Hasan et al. 2010). However,
in Calu-3 cells, knockdown of VAMP2 or VAMP3 did not
affect basal or agonist-stimulated mucin secretion (Fig. 4).
These results suggest that exocytosis of mucin granules
from airway goblet cells probably requires VAMP8.
Knockdown of VAMP8 expression reduces mucin
secretion in WD-HBE cells
To further investigate the effects of reducing VAMP8
expression on mucin exocytosis, the three most
effective VAMP8 siRNA sequences (VAMP8 mRNA
knockdown >85%) were individually cloned in retroviral
vectors to be expressed as short hairpin RNAs in Calu-3
and WD-HBE cells. Calu-3 cells stably expressing any
of the three VAMP8 shRNAs (shRNA A, B and C)
Figure 3. VAMP8 siRNA decreases mucin secretion in Calu-3 cells
Calu-3 cells were transfected with a mix of four VAMP8 siRNA oligos, or GAPDH siRNA (control). After 96 h,
VAMP8 mRNA levels were assessed by quantitative RT-PCR (A), and protein levels for VAMP8 (B) and MUC5AC
(C), were determined by immuno-slot blot. Mucin secretion was assessed in the extracellular bath after 2 h in
resting conditions (basal) and 10 min after adding vehicle or 100 μM PAR1 + 100 μM PAR2 peptide agonists (D).
The data are the mean ± SEM of quadruplicate samples (n = 2), and are expressed as % of control cells (A, B, C)
and arbitrary units (D); ∗P < 0.01 VAMP8 vs. GAPDH siRNAs (A, B, D), and †P < 0.01 agonist vs. vehicle (D).
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displayed a marked reduction in VAMP8 mRNA levels
(Fig. 5A) (note: shRNA C and shRNA A produced
very similar results, therefore shRNA C data are not
illustrated in the figures). VAMP8 protein levels were
nearly undetectable in shRNA-expressing cells (2 ± 2%
and 100 ± 9% in shRNA- and vector-expressing cells,
respectively). In contrast, mRNA levels for MUC5AC
or other VAMPs were not affected (Fig. 5A). Immuno-
cytochemical examination of the cell cultures indicated
that there were no phenotypic changes, i.e. goblet cell
distribution, or intracellular mucin content (MUC5AC
staining) in shRNA-expressing compared to mock
vector-expressing Calu-3 cells (Fig. 5B). MUC5AC protein
content was also unchanged (103 ± 12% and 100 ± 8% in
shRNA- vs. vector-expressing cells, respectively).
Basal secretion appeared to be elevated in Calu-3 cells
expressing empty and shRNA-containing vectors (Fig. 5C)
compared to Calu-3 cells transfected with siRNAs (Figs 3
and 4). These changes in basal secretion may not be
related to the expression of viral vectors, since similar
variability in the levels of basal mucin secretion is observed
in uninfected Calu-3 cells (L. Moussa and S. M. Kreda,
unpublished observation). However, like Calu-3 cells
expressing VAMP8 siRNAs, VAMP8 shRNA-expressing
cells displayed a sharp reduction in mucin secretion in
basal conditions, as well as in response to the PAR agonist
thrombin and the patho-physiologically relevant mucin
secretagogue human neutrophil elastase (Park et al. 2005;
Kreda et al. 2010a,b) (note, Calu-3 cells do not express
P2Y2 receptors; Kreda et al. 2007) (Fig. 5C).
To validate the results obtained in Calu-3 cells in
an alternative and near-physiological cell model system,
mucin secretion was investigated in WD-HBE cells
infected with the VAMP8 shRNA-encoding retroviral
vectors tested in Calu-3 cells. As in Calu-3 cells, WD-HBE
cells expressing VAMP8 shRNA displayed a marked
decrease in VAMP8 mRNA with no effect on mRNA
levels for MUC5AC, MUC5B or other VAMPs (Fig. 6A). As
expected, VAMP8 protein levels were nearly undetectable
in shRNA-expressing cells (2 ± 3% and 100 ± 12%
in shRNA- vs. vector-expressing cells, respectively).
No phenotypic changes, i.e. goblet cell distribution
or intracellular mucin content (AB-PAS staining and
MUC5AC intracellular protein content), were observed
in shRNA-expressing compared to vector-expressing
WD-HBE cells (Fig. 6B and C). Importantly, VAMP8
shRNA-expressing cells displayed a profound reduction
in mucin secretion in basal conditions and in response to
the potent mucin secretagogues neutrophil elastase, PAR1
and PAR2 agonists, and the P2Y2 receptor agonist ATPγS,
a non-hydrolysable ATP molecule (Davis & Lazarowski,
2008) (Fig. 6D).
Mucin secretion measured with a MUC5AC anti-
body (Fig. 6D) or by the PABH method (total mucins
(MUC5AC + MUC5B) Conway et al. 2003) produced
identical results (not shown).
VAMP8 knockdown expression is effective in
reducing mucin secretion in mucous-metaplastic
airway epithelium
Mucous metaplasia with mucin hypersecretion is a feature
of obstructive lung diseases (e.g. CF, COPD and asthma).
To test whether VAMP8 is essential for mucin exocytosis
in airway epithelia exhibiting inflammation-induced
Figure 4. VAMP2 and VAMP3 siRNA does not affect mucin secretion in Calu-3 cells
Calu-3 cells were transfected with a mix of four VAMP2 or VAMP3 siRNA oligos, or siGLO Green (control). After
96 h, VAMP mRNA (A) and protein (B) levels, intracellular MUC5AC protein levels (C) and mucin secretion (D)
were assessed as in Fig. 3 in VAMP2, VAMP3 and control silenced Calu-3 cells. The data are the mean ± SEM of
triplicate samples (n = 2), and are expressed as % of control cells (A, B, C) and arbitrary units (D); ∗P < 0.01 VAMP
siRNA vs. siGlo green (A, B), and †P < 0.01 agonist vs. control (D).
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mucous metaplasia, VAMP8 shRNA-expressing WD-HBE
cells were challenged with IL-13 (Okada et al. 2011)
or supernatant of mucopurulent material (SMM) from
diseased CF lungs (Ribeiro et al. 2005).
IL-13 treatment induced mucous metaplasia in both
mock vector- and VAMP8 shRNA-expressing WD-HBE
cells. Both MUC5AC and MUC5B mRNA levels were
significantly elevated in IL-13-treated cell cultures
compared to naı̈ve cell cultures; MUC5AC showed a much
larger increase in mRNA levels than MUC5B (e.g. ∼20-
vs. ∼5–fold for MUC5AC and MUC5B, respectively).
The number of goblet cells increased similarly (∼7-
to 25–fold) in both vector- and shRNA-expressing
WD-HBE cells in response to IL-13 exposure. The
intracellular mucin protein content (Fig. 7A) and the
histological characteristics (i.e. goblet cell number,
AB-PAS staining levels; Fig. 7B) were undistinguishable
between VAMP8 shRNA- and mock-expressing cell
cultures exposed to IL-13, that were undisturbed for
at least 24 h before staining. Importantly, despite the
metaplastic increase in mucin-producing cells elicited
by IL-13, VAMP8 expression knockdown effectively
reduced mucin secretion both in basal conditions and
in response to ATPγS (Fig. 7C). Similar results were
observed with mucin secretagogues neutrophil elastase
and PAR agonists (mucin secretion expressed in arbitrary
Figure 5. VAMP8 knockdown reduces mucin secretion in Calu-3 cells
Calu-3 cells were infected with retroviral vectors to stably express VAMP8 shRNAs (shRNA A, shRNA B). A,
mRNA levels assessed by quantitative RT-PCR in Calu-3 cells expressing two independent VAMP8 shRNAs. B,
confocal microscopy images of MUC5AC mucin granule immunostaining (white) and quantification of MUC5AC
immunostaining in Calu-3 cells expressing mock vector or VAMP8 shRNAs that were maintained undisturbed for
24 h; scale bar, 20 μm. C, mucin secretion in Calu-3 cells performed as in Fig. 3. Agonists were incubated for
20 min; neutrophil elastase (200 nM), PAR agonist thrombin (50 nM). The data are the mean ± SEM of triplicate
samples (n = 2), and are expressed in reference to control cells (A) and arbitrary units (B, C); ∗P < 0.01 VAMP8
shRNA vs. vector, and †P < 0.01 vector agonist vs. vector vehicle (C).
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Figure 6. VAMP8 knockdown reduces mucin secretion in WD-HBE cells
HBE cells were independently infected with retroviral vectors encoding two VAMP8 shRNA sequences,
antibiotic-selected, and cultivated on permeable supports under air–liquid interface for 21–28 days to produce
WD-HBE cell cultures stably expressing VAMP8 shRNAs. A, mRNA levels assessed by quantitative RT-PCR in WD-HBE
cells expressing VAMP8 shRNAs. B, total MUC5AC protein content within cell cultures undisturbed for 24 h. C,
AB-PAS staining and staining quantification of WD-HBE cells expressing vector and VAMP8 shRNA that were
undisturbed for 24 h; scale bar, 10 μm. D, mucin secretion in WD-HBE cells performed as in Fig. 3. Agonists were
incubated for 20 min; elastase (200 nM), PAR1-peptide (100 μM) + PAR2-peptide (100 μM) and ATPγ S (100 μM).
The data are the mean ± SEM of triplicate samples and are expressed in arbitrary units; ∗P < 0.01 VAMP shRNA
vs. vector, and †P < 0.01 vector agonist vs. vector vehicle (D). Similar results were obtained in three independent
experiments performed with WD-HBE cells cultured from different human subjects and two different VAMP8
shRNAs.
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units was reduced 65 ± 15% for neutrophil elastase, and
49 ± 17% for PAR agonists in VAMP8 shRNA- compared
to vector-expressing cells treated with elastase and PAR
agonists, respectively, in separate experiments).
SMM induced mucous metaplasia with similar efficacy
in WD-HBE cell cultures expressing vector or VAMP8
shRNA. The number of goblet cells increased similarly
(∼3- to 6–fold) in both vector- and shRNA-expressing
WD-HBE cells in response to SMM exposure. MUC5AC
mRNA levels increased 8.0 ± 0.5- and 8.6 ± 0.1-fold and
MUC5B increased 3.9 ± 0.3- and 4.7 ± 0.2–fold in vector-
and shRNA- expressing cells, respectively, after SMM
treatment. The levels of MUC5AC protein (Fig. 8A), the
number of goblet cells/levels of AB-PAS staining (Fig. 8B)
were similar in mock vector- and shRNA-expressing cell
cultures induced with SMM. Importantly, mucin secretion
stimulated by ATPγS and under basal conditions was
significantly reduced in SMM-inflamed WD-HBE cells
with VAMP8 knockdown (Fig. 8C).
These results suggest that VAMP8 knockdown can
effectively reduce mucin secretion in airway epithelium
displaying mucous metaplasia and mucin hypersecretion.
Mucin secretion is reduced in the VAMP8 KO mouse
Next, we tested the hypothesis that VAMP8 is required for
physiological mucin secretion from native airways using
the VAMP8 KO mouse. In our hands, these animals do not
appear to develop lung disease.
Unlike human airways, the main secretory cell type
in mouse airways is the Clara cell while very few/no
AB-PAS-positive goblet cells are observed and mucin
secretion is very low (Davis & Dickey, 2008). In these (base-
line) conditions, it is difficult to identify a block/inhibition
on mucin secretion. Therefore, the number of goblet cells
and the levels of mucin secretion in the airways were
increased by inducing mucous metaplasia in these animals
Figure 7. VAMP8 knockdown reduces mucin secretion in WD-HBE cells with IL-13-induced mucous
metaplasia
WD-HBE cell cultures stably expressing VAMP8 shRNAs were treated with IL-13 (10 ng day−1, 5 days). A, total
MUC5AC protein content within cell cultures undisturbed for 24 h. B, AB-PAS staining and staining quantification
of WD-HBE cells expressing vector and VAMP8 shRNA that were undisturbed for 24 h; scale bar, 20 μm. C, mucin
secretion in WD-HBE cells performed as in Fig. 3. Agonist ATPγ S (100 μM) was incubated for 20 min. The data
are the mean ± SEM of triplicate samples, and are expressed in arbitrary units; ∗P < 0.01 VAMP shRNA vs. vector,
and †P < 0.01 vector agonist vs. vector vehicle (C). Similar results were obtained in two independent experiments
performed with WD-HBE cells obtained from different human subjects and two different VAMP8 shRNAs.
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with IL-13. Under these allergic-inflammatory conditions,
Clara cells switch to a mucous phenotype and the air-
ways of IL-13-stimulated mice exhibit high numbers of
AB–PAS-positive goblet cells and high rates of mucin
secretion (Davis & Dickey, 2008; Anagnostopoulou et al.
2010). As expected, WT, VAMP8 HET and VAMP8 KO
mice treated with IL-13 displayed mucous metaplasia as
indicated by high levels of AB-PAS staining in the trachea
of these animals (Fig. 9A). Quantification of the AB-PAS
staining indicated that no differences in the number of
goblet cells or intracellular mucin content were evident
among the different mouse groups in the absence of a
mucin secretagogue (Fig. 9B). Tracheas were stimulated
ex vivo with ATP to induce mucin secretion. WT and
HET tracheas displayed low levels of AB-PAS staining after
ATP-promoted mucin granule secretion (Fig. 9A and B).
There were no statistically significant differences between
HET vs. WT. In contrast, KO tracheas had no significant
change in the levels of AB-PAS staining in response to
ATP (Fig. 9A and B). These data suggest that VAMP8
KO mice have an impediment in agonist-regulated mucin
exocytosis.
The mucin content in the BAL reflects the amount
of mucin already secreted into the airway lumen and
a variable amount of mucin being secreted in response
to stimuli generated during the BAL collection. Analysis
of the BALs from IL-13-treated animals showed that
the mucin content (MUC5B) was decreased in VAMP8
KO compared to WT and HET mice (Fig. 9C and D).
(Note: there is no reliable antibody that recognizes mouse
MUC5AC; antibodies against human MUC5AC, like the
one utilized in the in vitro studies (Figs 3–8) are not
reliable to detect/quantify mouse MUC5AC.) There were
no statistically significant differences between HET vs. WT.
Figure 8. VAMP8 knockdown reduces mucin secretion in WD-HBE cells with SMM-induced
inflammation/mucous metaplasia
WD-HBE cell cultures stably expressing VAMP8 shRNAs were treated with SMM (5 days). A, total MUC5AC protein
content within cell cultures undisturbed for 24 h. B, AB-PAS staining and staining quantification of WD-HBE
cells expressing vector and VAMP8 shRNA that were undisturbed for 24 h; scale bar, 20 μm. C, mucin secretion
in WD-HBE cells performed as in Fig. 3. Agonist ATPγ S (100 μM) was incubated for 20 min. The data are the
mean ± SEM of triplicate samples, and are expressed in arbitrary units; ∗P < 0.01 VAMP shRNA vs. vector, and
†P < 0.01 vector agonist vs. vector vehicle (C). Similar results were obtained in two independent experiments
performed with WD-HBE cells obtained from different human subjects.
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A decreased level of BAL mucin in VAMP8 KO mice further
suggests that the absence of VAMP8 expression blocks
mucin granule exocytosis.
Discussion
The exocytotic release of gel-forming mucins into the
airway lumen from specialised granules in goblet cells
reflects a tightly regulated process that sustains the thin
mucus layer covering the airway surfaces. Our knowledge
of the proteins involved in the regulation of airway mucin
granule exocytosis remains incomplete. In this study, we
identified VAMP8 as a v-SNARE (R–SNARE) in mucin
granules of airway goblet cells.
Amongst the 30+ SNARE genes, only seven v-SNAREs
or VAMPs have been identified in the human genome
(Advani et al. 1998; Burgoyne & Morgan, 2003; Brunner
et al. 2009). Individual SNARE proteins localize to distinct
organelles, and VAMPs are differentially expressed in
different tissues, suggesting that each VAMP has a relatively
selective role in vesicle trafficking events (Advani et al.
1998; Chen & Scheller, 2001; Burgoyne & Morgan, 2003;
Brunner et al. 2009). VAMP8 was originally associated
with endosomal membrane fusion activity (Advani et al.
1998; Ho et al. 2008), but recent studies in the VAMP8
KO mouse suggest that VAMP8 is critical for regulated
exocytosis of secretory granules in pancreatic acini and
other exocrine glands (Wang et al. 2004, 2007), histamine
granules from mast cells, and dense and α-granules from
platelets (Ren et al. 2007; Tiwari et al. 2008; Graham et al.
2009).
Similarities between the calcium-dependent exocytosis
of mucin granules from airway goblet cells and pancreatic
acinar zymogen granule exocytosis have been observed
(Burgoyne & Morgan, 2003; Davis & Dickey, 2008).
However, the function of VAMP8 in secretory cells of
lung epithelia has not been studied. We have previously
established that VAMP8 is associated with mucin granules
purified from airway goblet cells (Kreda et al. 2010b), the
Figure 9. Airway mucin secretion is
reduced in the VAMP8 KO mouse
A, tracheas dissected from IL-13-induced WT
and VAMP8 knockout heterozygous (HET) and
homozygous (KO) littermate mice were
incubated with vehicle or ATP, fixed and stained
with AB-PAS as described in Methods. Tracheas
from age-matched mice with no IL-13
treatment (Naı̈ve) are shown for comparison.
Images are representative longitudinal views of
mouse tracheas, dark purple-blue staining
indicates AB-PAS-positive substances (e.g.
mucin); scale bar, 30 μm. B, AB-PAS staining
quantification. C, Western blot of mouse BALs
to reveal the mucin content using an antibody
that recognizes mouse MUC5B; arrowhead
indicates the position of MUC5B. D, Western
blot quantification. The data presented in both
graphs are expressed in arbitrary units (A.U.),
and represent the mean ± SEM of two
experiments (total number of animals: WT
(n = 12), KO (n = 12) and HET (n = 8)),
∗P < 0.01.
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main secretory cell in the superficial epithelium lining the
human airways. Our current data indicate that VAMP8
was localised in the mucin granules of goblet cells in
native human airway epithelia and in in vitro models
of human airway epithelium. Moreover, of the seven
VAMPs, VAMP8 showed the highest level of expression
in airway epithelial cells (Table 1 and Fig. 1C). For
example, VAMP8 is expressed ∼5–10 times higher than
VAMP3, and 10–30 times higher than VAMP2, VAMP5
and VAMP7. Of these VAMP proteins, VAMP2, VAMP3
and VAMP7 (but not VAMP5) have been implicated in
vesicle exocytosis of secretory cells (Advani et al. 1998;
Chen & Scheller, 2001; Burgoyne & Morgan, 2003; Schraw
et al. 2003; Deak et al. 2004; Wang et al. 2004; Pocard et al.
2007; Weng et al. 2007; Tiwari et al. 2009; Hasan et al.
2010). However, our studies suggest that VAMP8 is the
main v-SNARE involved in exocytosis of mucin granules
from airway goblet cells.
VAMP8 is the primary SNARE for acute
agonist-regulated mucin secretion from airway
goblet cells
Mucin granules, like other dense-core secretory granules,
are released exocytotically by basal/tonic and acute
regulation by Ca2+-mobilizing extracellular agonists
(Burgoyne & Morgan, 2003; Kreda et al. 2007; Davis
& Dickey, 2008). The functional role of VAMP8
in agonist-regulated mucin granule exocytosis was
investigated in vitro by specifically knocking-down
VAMP8 expression, using siRNA and shRNA approaches,
in two different models of goblet cell-containing air-
way epithelium, i.e. Calu-3 cells and WD-HBE cells.
Short interfering RNAs (siRNAs and shRNAs) targeting
VAMP8 efficiently reduced VAMP8 expression levels
without affecting the expression levels of mucins (e.g.
MUC5AC), or that of other VAMPs that are significantly
expressed in airway epithelial cells and have been
associated with exocytosis (i.e. VAMP2, VAMP3 and
VAMP7). Importantly, VAMP8 silencing was effective in
reducing mucin secretion stimulated by physiologically
relevant mucin secretagogues. For example, nucleotides
that activate apically expressed P2Y2 receptors (Davis &
Lazarowski, 2008), proteases and synthetic peptides that
activate basolaterally expressed PARs (Kreda et al. 2010b),
and basolateral neutrophil elastase (through an undefined
mechanism) (Kreda et al. 2010a) stimulated airway
epithelial mucin secretion in a VAMP8-dependent manner
(Figs 3, 5 and 6).
The findings in the in vitro studies using human airway
epithelial cells were further explored in the VAMP8 KO
mouse with IL-13-induced mucous metaplasia. In VAMP8
KO mice, unlike their WT and (VAMP8) HET-matched
controls, tracheal mucin granule secretion was reduced
post ex vivo stimulation with ATP as shown in Fig. 9. Thus,
regulated exocytosis of mucin granules in airway goblet
cells in vivo also requires VAMP8.
In neurons, VAMP2 but not VAMP8 is essential
for rapid synaptic vesicle release (Deak et al. 2004).
VAMP8 is also not crucial for regulated exocytosis of
hormone-containing granules from pancreatic cells or
cytokines-containing granules from mast cells (Wang et al.
2004; Tiwari et al. 2008). Moreover, proteomic analyses of
secretory organelles from different tissues indicated that
VAMP8 was present in some but not all secretory vesicles
(Brunner et al. 2009). Thus, VAMP8 appears to display
selectivity with respect to regulated exocytotic pathways
(Tiwari et al. 2008). In our in vitro studies, although
the expression of VAMP8 was abolished, the expression
levels of other VAMPs were not different in VAMP8
knocked-down vs. normal cells. Moreover, knockdown
expression of VAMP2 or VAMP3 did not affect mucin
secretion. Thus, most probably, VAMP8, but not other
VAMPs, was responsible for the reduction in mucin
secretion observed in VAMP8-silenced cells. Similarly,
VAMP8 and no other VAMPs appears to be essential in
agonist-regulated exocytosis of secretory granules from
exocrine secretory cells (Wang et al. 2004, 2007), platelets
(Ren et al. 2007), mast cells (Tiwari et al. 2008) and
macrophages (Pushparaj et al. 2009).
Our data indicate that VAMP8 is the primary v-SNARE
in the exocytic core assembled during agonist-regulated
exocytosis of airway mucin granules. Although further
studies are needed, we could speculate about the identity
of VAMP8 partners in the SNARE core of airway goblet
cells. For example, it has been postulated that SNAP23
or SNAP25 is one of the t–SNARES in the exocytotic
core of mucin granules (Davis & Dickey, 2008; Evans &
Koo, 2009). SNAP23 has been shown to regulate apical
exocytosis in polarised epithelial MDCK cells (Low et al.
1998). Deep sequencing mRNA data showed that SNAP23
but not SNAP25 is highly expressed in both Calu-3 cells
(data expressed in RPKM, 10.60 ± 0.13 vs. 0.37 ± 0.03
for SNAP23 and SNAP25, respectively) and in WD-HBE
cells (S. Randell, unpublished results). Thus, it is plausible
that SNAP23 is the t-SNARE partner of VAMP8 in goblet
cells. The second t-SNARE in the core complex could be
syntaxin 3. We have previously established that syntaxin
3 is specifically localised apically in airway goblet cells
(Kreda et al. 2007), and syntaxin 3 has been implicated
in regulating apical vesicle exocytosis in polarised MDCK
cells (Low et al. 1998; Kreitzer et al. 2003).
VAMP8 regulates the basal secretion of mucins
In the absence of acute agonist stimulation, a constant,
low rate secretion of mucin is observed in the airway
epithelial surface, which is defined as basal secretion (Davis
& Dickey, 2008; Evans & Koo, 2009; Zhu et al. 2008). Basal
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mucin secretion most probably reflects low, but constant
tonic stimulation of goblet cells. It is critical to maintain
the properties of the mucus layer bathing the airway lumen
and support proper functioning of the MCC activities in
the lung (Boucher, 2007; Kreda et al. 2007, 2010b; Davis
& Dickey, 2008; Evans & Koo, 2009; Tuvim et al. 2009).
Whether the same SNARE and regulatory proteins
participate in the exocytosis of the mucin granule in
response to tonic vs. acute agonist stimulation has
not been defined (Davis & Dickey, 2008; Zhu et al.
2008). For example, deletion of Munc13–2 indicated
that this exocytotic priming protein is not essential for
agonist-stimulated mucin secretion, but it does appear
to regulate a tonically active, baseline mucin secretory
pathway in the airways (Zhu et al. 2008). In the exocrine
glands of the VAMP8 KO mouse, agonist-stimulated
secretion of zymogen granules was reduced, while basal
secretion was preserved (Wang et al. 2004, 2007).
Tonically active basal mucin secretion cannot be
unambiguously measured in vivo in the airways but
can be estimated by histological, BAL mucin content
and ex vivo mucin secretion analyses. Our studies in
the IL-13-induced VAMP8 KO mouse revealed that
the histological evaluation of tracheas (without ATP
stimulation) was not discriminatory amongst genotypes.
In the intact mouse, BAL mucin content was reduced in
the IL-13-induced VAMP8 KO mouse compared to WT
and (VAMP8) HET-matched controls. These data could
suggest a regulatory role of VAMP8 in tonically active
basal secretion in vivo in the airways. However, the mucin
content in the BAL reflects not only basal secretion, but
also mucin secreted into the lumen in response to the
manoeuvres of BAL collection.
Unlike the in vivo studies in the lung, in vitro studies in
cultured airway epithelial cells allowed direct evaluation
of the role of VAMP8 in mediating basal mucin secretion.
Our in vitro studies in airway epithelial cells indicated that
VAMP8 knockdown produced not only a reduction in the
agonist-stimulated secretion of mucins, but also in the
tonically active basal secretion as well. Despite a reduction
in basal secretion, the mucin content within goblet cells
was not significantly increased in VAMP8-deficient cell
cultures that were undisturbed for at least 24 h. This
finding is in contrast to observations in the airway
epithelia of Munc13–2 knockout mice showing increased
intracellular mucins with reduced basal secretion (Zhu
et al. 2008). The lack of mucin accumulation within
VAMP8-deficient airway epithelial cell cultures could be
explained by a slow rate of mucin granule synthesis in these
cell cultures; thus, accumulation of granules would not be
noticeably higher over 24 h even if the basal secretion is
decreased in VAMP8-deficient vs. normal cell cultures.
Alternatively, only a small pool of mucin granules may
participate in basal secretion while a much larger pool of
granules would be available for secretion in response to
an acute agonist; thus, in resting cell cultures it may be
difficult to detect significant intracellular accumulation of
mucins.
Further study will be necessary to unambiguously
understand the role of VAMP8 regulating tonically active
basal secretion of mucins in vivo in the lung.
VAMP8 in mucus-hypersecretory lung diseases
Lung infection and inflammation induces airway
epithelial remodelling, producing a goblet cell-dominated
epithelium with increased mucin secretion and defective
MCC activities. Thus, lung mucin hypersecretion,
leading to mucus obstruction of the airways, is a
major pathological feature of chronic lung diseases
(Davis & Dickey, 2008; Evans & Koo, 2009; Fahy
& Dickey, 2010). Current therapies focus on the use
of anti-inflammatory agents such as corticosteroids to
reduce mucous metaplasia (a consequence of epithelial
inflammation), aerosolised hypertonic saline solution,
DNA severing enzymes and reducing agents to decrease
mucus viscosity, and beta-agonists to stimulate ciliary
action and improve mucociliary clearance. However, these
treatments have limited efficacy (Evans & Koo, 2009).
Inhibition of mucin secretion is a desirable therapeutic
strategy and recent developments in the field reveal
potential targets for blocking this activity in the diseased
lung (Singer et al. 2004; Davis & Dickey, 2008; Evans
& Koo, 2009; Tuvim et al. 2009). Our studies in
models of airway epithelium with induced inflammation
and goblet cell metaplasia (i.e. chronic treatment with
IL-13 and SMM of VAMP8-silenced cell cultures and
in vivo IL-13-treatment of VAMP8 KO mice) indicated
that reduction of VAMP8 expression can efficiently
reduce both tonically- and agonist-regulated secretion of
mucins in inflamed/hypersecretory airway epithelia. Thus,
targeting VAMP8 to reduce its expression/activity in air-
way goblet cells may be a viable therapeutic approach
for improvement of obstructive lung diseases. SNARE
proteins are targets of potent natural toxins that exhibit
relative specificities (Dolly et al. 2009; Fletcher et al. 2010).
For example, botulinum toxins, mainly type A (and to a
lesser extent type B), are being used clinically with notable
success for the treatment of numerous human disorders
involving over-activity of cholinergic nerves innervating
muscles and glands (Dolly et al. 2009). Emergence of
additional toxin-based therapeutics is anticipated based
on in-depth knowledge of botulinum toxin serotypes and
other toxins (Fletcher et al. 2010) that target SNARES
to devise new engineered versions for inhibitory actions
in non-neuronal cell types. It is plausible that such
engineered toxins could be targeted to VAMP8 to disrupt
mucin granule exocytosis specifically in the airways to
improve mucus obstruction and MCC in chronic lung
diseases.
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In summary, the present study identifies VAMP8 as a
v-SNARE for mucin granules in airway epithelial goblet
cells. VAMP8 is associated with mucin granules in the
goblet cells of human airway epithelia and is a critical
SNARE for mucin granule exocytosis in response to
acute agonist regulation. Basal secretion of mucins is also
regulated by VAMP8. Since reduction in mucin secretion
is a desirable therapeutic approach for many severe lung
diseases, VAMP8 may be a potential target for drug
development.
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